Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Bolt Biotherapeutics ( (BOLT) ) has shared an announcement.
Dr. Mahendra Shah resigned from Bolt Biotherapeutics’ Board of Directors, effective December 31, 2024, for personal reasons. Following his resignation, Dr. Jakob Dupont was appointed to the Audit Committee and the Nominating and Corporate Governance Committee, ensuring continuity in the company’s governance.
More about Bolt Biotherapeutics
YTD Price Performance: -55.36%
Average Trading Volume: 149,035
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $19.14M
See more insights into BOLT stock on TipRanks’ Stock Analysis page.